Are there differences among anti-TNFa biological drugs?
Objective: To provide an analysis and a guide tool in using TNFa-antagonists in the current clinical practice. Methods: Review of the literature on the differences among the three TNFa-antagonists in terms of molecular structure, mechanism of action, pharmacokinetics, effects on the immune and neuro...
Saved in:
Main Author: | G. Valesini (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2011-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of anti-TNFa biological drugs
by: G. Valentini, et al.
Published: (2011) -
Biologic therapy with anti-TNFa in rheumathoid atrhritis
by: G. Ferraccioli
Published: (2011) -
Approved indications and other possible utilizations of anti-TNFa biologic drugs
by: C. Montecucco, et al.
Published: (2011) -
Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases
by: G. Lapadula
Published: (2011) -
Methylation levels of the TNFA gene are different between Graves' and Hashimoto's diseases and influenced by the TNFA polymorphism
by: Emi Morita, et al.
Published: (2018)